相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer
Andrew C. Johns et al.
JOURNAL OF GERIATRIC ONCOLOGY (2021)
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
Rafaela Kramer et al.
EUROPEAN JOURNAL OF CANCER (2021)
Pembrolizumab-induced thrombotic thrombocytopenic purpura
Marcus S. R. Dickey et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort
Abdul Rafeh Naqash et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo A Secondary Analysis of a Randomized Clinical Trial
Alexander M. M. Eggermont et al.
JAMA ONCOLOGY (2020)
Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
Xiaoxiang Zhou et al.
BMC MEDICINE (2020)
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors
Denis Maillet et al.
EUROPEAN JOURNAL OF CANCER (2020)
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Bairavi Shankar et al.
JAMA ONCOLOGY (2020)
Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy
Hussein A. Assi et al.
FUTURE SCIENCE OA (2020)
Thrombotic thrombocytopenic purpura associated to dual checkpoint inhibitor therapy for metastatic melanoma
Anne Lafranchi et al.
CEN CASE REPORTS (2020)
Rare case of life-threatening thrombocytopenia occurring after radiotherapy in a patient treated with immune checkpoint inhibitor
Aurore Hendrix et al.
BMJ CASE REPORTS (2020)
Disseminated Intravascular Coagulation in Cancer: An Update
Marcel Levi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2019)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Satya Das et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
Naoto Okada et al.
CLINICAL THERAPEUTICS (2019)
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
Biagio Ricciuti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
Takeo Hasegawa et al.
JOURNAL OF MEDICAL CASE REPORTS (2019)
Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer
Hidenori Mori et al.
RESPIRATORY MEDICINE CASE REPORTS (2019)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer
Dwight H. Owen et al.
CLINICAL LUNG CANCER (2018)
Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysis
Fausto Petrelli et al.
EUROPEAN JOURNAL OF CANCER (2018)
Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
Cheng Xu et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
Nicolas Delanoy et al.
Lancet Haematology (2018)
Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors
Alexey Youssef et al.
CASE REPORTS IN HEMATOLOGY (2018)
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy
Hammad Shafqat et al.
SEMINARS IN ONCOLOGY (2018)
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis
Sebastien Le Burel et al.
EUROPEAN JOURNAL OF CANCER (2017)
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
Eileen Shiuan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Management of toxicities of immune checkpoint inhibitors
Lavinia Spain et al.
CANCER TREATMENT REVIEWS (2016)
Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure
R. Todd Stravitz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Chemotherapy induced thrombocytopenia in pediatric oncology
Gevorg Tarnarnyan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
The pathophysiology of thrombocytopenia in chronic liver disease
Oscar Mitchell et al.
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2016)
Thrombocytopenia in Adult Cancer Patients Receiving Cytotoxic Chemotherapy Results from a Retrospective Hospital-Based Cohort
Maarten J. ten Berg et al.
DRUG SAFETY (2011)
Platelets and viruses: an ambivalent relationship
Claire Flaujac et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management
R. H. Aster et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Hematologic effects of linezolid: Summary of clinical experience
SL Gerson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro
H Isomura et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
